International Patent: PLATFORM FOR EXPRESSION OF NON-REPLICATING (CONVENTIONAL) MESSENGER RNA (MRNA) FOR THE DEVELOPMENT OF VACCINES AND THERAPIES, NUCLEIC ACID SEQUENCE, COMPOSITION, USE, METHOD OF TREATMENT AND/OR PREVENTION OF DISEASES, AND METHOD FOR PREPARING THE COMPOSITION

GENEVA, July 1 -- FUNDAÇÃO OSWALDO CRUZ filed a patent application (BR2025/050533) for “PLATFORM FOR EXPRESSION OF NON-REPLICATING (CONVENTIONAL) MESSENGER RNA (MRNA) FOR THE DEVELOPMENT OF VACCINES AND THERAPIES, NUCLEIC ACID SEQUENCE, COMPOSITION, USE, METHOD OF TREATMENT AND/OR PREVENTION OF DISEASES, AND METHOD FOR PREPARING THE COMPOSITION”. With publication no. WO/2026/123082, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/11

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....